Praxbind Adverse Reactions

idarucizumab

Manufacturer:

Distributor:

DKSH

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

In a phase III trial the safety of Praxbind has been evaluated in 503 patients, who had uncontrolled bleeding or required emergency surgery or procedures and were under treatment with Pradaxa, as well as in 224 volunteers in phase 1 trials.
No adverse reactions have been identified.

View ADR Monitoring Form

Exclusive offer for doctors

Already a member? Sign in